Connection

Daynna Wolff to Polymorphism, Single Nucleotide

This is a "connection" page, showing publications Daynna Wolff has written about Polymorphism, Single Nucleotide.
Connection Strength

0.950
  1. Clinical utility of concurrent single-nucleotide polymorphism microarray on fresh tissue as a supplementary test in the diagnosis of renal epithelial neoplasms. Am J Clin Pathol. 2015 Nov; 144(5):731-7.
    View in: PubMed
    Score: 0.420
  2. Clonal diversity analysis using SNP microarray: a new prognostic tool for chronic lymphocytic leukemia. Cancer Genet. 2011 Dec; 204(12):654-65.
    View in: PubMed
    Score: 0.320
  3. Whole-Genome Single Nucleotide Polymorphism Microarray for Copy Number and Loss of Heterozygosity Analysis in Tumors. Methods Mol Biol. 2019; 1908:89-111.
    View in: PubMed
    Score: 0.131
  4. Establishment and genomic characterization of a sporadic malignant peripheral nerve sheath tumor cell line. Sci Rep. 2021 03 11; 11(1):5690.
    View in: PubMed
    Score: 0.038
  5. Chromothripsis in Two Patients With Renal Cell Carcinoma: A Case Series. Clin Genitourin Cancer. 2017 02; 15(1):e137-e143.
    View in: PubMed
    Score: 0.027
  6. Altered promoter usage characterizes monoallelic transcription arising with ERBB2 amplification in human breast cancers. Genes Chromosomes Cancer. 2006 Nov; 45(11):983-94.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.